# Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer

> **NCT00104130** · PHASE2 · TERMINATED · sponsor: **Bristol-Myers Squibb** · enrollment: 53 (—)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** KOS-862

## Key facts

- **NCT ID:** NCT00104130
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-12
- **Primary completion:** —
- **Final completion:** 2005-02
- **Target enrollment:** 53 (—)
- **Last updated:** 2008-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00104130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00104130, "Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00104130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*